Skip to content

Author

S. Abdulazeez

We have 1 of 81 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Telmisartan Repurposing Targets Novel Biomarkers for Precision Colorectal Cancer Therapy

Telmisartan is a promising candidate for drug repurposing for CRC treatment and capable of modulating selected novel biomarkers CLUH and SLC11A2, according to in silico predicted deleterious mutations.

Sarah Hunachagi, H. H. Alqudihi, S. Abdulazeez et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.